openPR Logo
Press release

PEGylated Proteins Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)

11-08-2023 03:39 AM CET | Health & Medicine

Press release from: Orion Market Research

PEGylated Proteins Market is Anticipated to Increase at a Stable

The global PEGylated proteins market is anticipated to grow at a considerable CAGR of 1.8% during the forecast period 2023-2030). The rising FDA approvals to increase therapeutic application of PEGylated proteins is a key factor driving the growth of the global PEGylated proteins market. For instance, in December 2022, Protalix BioTherapeutics, Inc., a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant cell based protein expression system, and Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected by rare diseases, announced that the US Food and Drug Administration (FDA) has accepted the resubmitted Biologics License Application (BLA) for pegunigalsidase alfa (PRX-102) for the proposed treatment of adult patients with Fabry disease.

Pegunigalsidase alfa is a purposefully-designed, long-acting recombinant, PEGylated, cross-linked ?-galactosidase-A investigational product candidate. The FDA indicated in the BLA filing communication letter that the resubmitted BLA was considered a complete, class 2 response and set an action date of May 9, 2023, under the Prescription Drug User Fee Act (PDUFA).

To Request a Sample of our Report on PEGylated Proteins Market: https://www.omrglobal.com/request-sample/pegylated-proteins-market

Market Coverage

The market number available for - 2022-2030
Base year- 2022
Forecast period- 2023-2030
Segment Covered-

By Products
By Application
By End-User
Regions Covered-

North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape- Thermo Fisher Scientific, Inc., Abcam plc, Enzon Pharmaceuticals, Inc., Merck KGaA, and Celares GmbH among others

A full Report of PEGylated Proteins Market is Available @ https://www.omrglobal.com/industry-reports/pegylated-proteins-market

PEGylated Proteins Market Report Segment

By Products

Consumables
Services
By End-User

Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Academic & Research Institutes
By Application

Cancer
Autoimmune Diseases
Hepatitis
Multiple Sclerosis
Hemophilia
Gastrointestinal Disorders
Other
PEGylated Proteins Market Report Segment by Region

North America

United States
Canada
Europe

UK
Germany
Spain
France
Italy
Rest of Europe
Asia-Pacific

India
China
Japan
South Korea
Rest of APAC
Rest of the World

Latin America
Middle East and Africa
Company Profiles

Abcam plc
Aurigene Pharmaceutical Services Ltd.
Celares GmbH
Creative PEGworks
Enzon Pharmaceuticals, Inc.
Laysan Bio, Inc.
Merck KGaA
NOF America Corp.
Profacgen
Thermo Fisher Scientific, Inc.
Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pegylated-proteins-market

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PEGylated Proteins Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029) here

News-ID: 3279771 • Views:

More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033. Infrastructure as Code (IaC) Service Market Overview The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to Understanding the Process
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033. Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,
Property Management Service Market Rising Demand and Growth Forecast Through 2033
Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033. Property Management Service Market Overview The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSilicon Technologies Co., Ltd., ZTE Corporation,
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033. 5G Chipset Market Overview The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT

All 5 Releases


More Releases for PEGylated

Rising Prevalence Of Lifestyle Diseases Is Driving Growth Of The PEGylated Prote …
The PEGylated Proteins Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the PEGylated Proteins Market Size and Projected Growth Rate? The pegylated proteins market, valued at $1.47 billion in 2024, is expected to grow to $1.68 billion in 2025, with a CAGR of 14.1%.
PEGylated Proteins Market Size: Strong Growth Ahead (2025-2032)
Latest Market Overview The global PEGylated proteins market is witnessing significant growth, driven by an expanding range of therapeutic applications and increasing demand for protein-based drugs. In 2024, the PEGylated proteins market is estimated to be valued at USD 7.5 billion, with forecasts projecting a robust growth trajectory through 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 8.2% during the forecast period. The rising
PEGylated Proteins Market to Witness Robust Expansion by 2024
Market Research Report Store offers a latest published report on PEGylated Proteins Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the PEGylated Proteins market will register a 3.9% CAGR in terms of revenue, the global market size will reach US$ 3819.7 million by 2024, from US$ 3275 million in 2019. In
PEGylated Proteins Market - Competitive Landscape and Key Product Segments
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in
PEGylated Proteins Market: Competitive Dynamics & Global Outlook 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global PEGylated Proteins market. PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/2882/global-pegylated-proteins-market Global PEGylated Proteins Market: Forecast by
PEGylated Proteins 2024 Market Research Report
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in